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Abstract
Attempts to apply artificial nano/micromotors for diverse biomedical applications have inspired a 
variety of strategies for designing new motors with unique propulsion mechanisms and functions. 
However, existing artificial motors are made exclusively of synthetic materials, which are subject 
to serious immune attack and clearance upon entering the bloodstream. Herein we report an 
elegant approach that turns natural red blood cells (RBCs) into functional micromotors with the 
aid of ultrasound propulsion and magnetic guidance. Iron oxide nanoparticles are loaded into the 
RBCs, where their asymmetric distribution within the cells results in a net magnetization, thus 
enabling magnetic alignment and guidance under acoustic propulsion. The RBC motors display 
efficient guided and prolonged propulsion in various biological fluids, including undiluted whole 
blood. The stability and functionality of the RBC motors, as well as the tolerability of regular 
RBCs to the ultrasound operation, are carefully examined. Since the RBC motors preserve the 
biological and structural features of regular RBCs, these motors possess a wide range of antigenic, 
transport, and mechanical properties that common synthetic motors cannot achieve and thus hold 
considerable promise for a number of practical biomedical uses.
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The development of nano/micromotors is a research area of intense activity due to numerous 
potential applications.1–8 While considerable attention has been given to catalytic motors 
that exhibit self-propulsion in the presence of a hydrogen peroxide fuel, many practical 
applications would require elimination of the need of chemical fuel.9–15 Several groups have 
thus explored fuel-free propulsion mechanisms based on externally applied magnetic or 
ultrasound fields.16–20 The increased capabilities and sophistication of these tiny fuel-free 
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motors hold considerable promise for directed drug delivery, biopsy, cleaning clogged 
arteries, precision nanosurgery, or localized diagnosis in hard-to-reach places. To fulfill 
these exciting potential applications, particular attention is drawn to the biocompatibility of 
the motors in biological environments and to their performance in undiluted biological 
media. The metallic or polymeric components of common artificial nano/micromotors are 
facing destructive immune attack once entering into the bloodstream due to the foreign 
nature of these materials.
Natural cells and their derivatives are highly optimized by nature for their unique in vivo 
functions and possess attractive features desired for systemic cargo delivery.21–23 As a 
result, various types of cells, such as red blood cells (RBCs, also named erythrocytes), white 
blood cells, macrophages, engineered stem cells and so on, have been employed to carry and 
deliver therapeutic or imaging agents.24,25 The intrinsic properties of these natural carriers 
have opened the door to creative cargo delivery strategies and novel biomaterials 
development. Among these cell-based carriers, RBCs are of particular interest owing to their 
vast availability, unique mechanical attribute, surface immunosuppressive property, and 
versatile cargo-carrying capability.26–28 As such, numerous RBCs based or inspired delivery 
systems have been recently developed for cargo delivery, relying on the prolonged transport 
property of RBCs in the bloodstream.29–32 However, there are no early reports on how to 
bestow active propulsion force upon the passively moving RBCs and thus to utilize the cells 
as a powerful autonomous micromotor.
Here we demonstrate the attractive behavior of an ultrasound-powered, magnetically-
switchable RBC-based micromotor (denoted RBC motor). Recent efforts have demonstrated 
that ultrasound field can trigger the propulsion of microscale objects, and that such 
movement is driven by the interaction between the objects and the distribution of acoustic 
forces within the field.33,34 The new RBC motors are prepared by loading iron-oxide 
nanoparticles into RBCs. The propulsion of the RBC motor can be attributed to the 
asymmetric distribution of iron oxide nanoparticles within the cell, which is critical for 
ultrasound-powered motion.35 The RBC motor is propelled by the pressure gradient 
generated by the ultrasound waves due to the inherent asymmetric geometry of the RBC as 
well as the asymmetric distribution of magnetic particles inside the RBCs. The latter also 
provides a net magnetization that enables magnetic alignment and guidance under acoustic 
propulsion. The magnetic guidance (orientation) of these RBC motors can be switched ‘On’ 
and ‘Off’ by applying an external magnetic field. The resulting RBC motors possess highly 
efficient, ultrasound-powered, magnetically-guided propulsion (Figure 1a). Of particular 
interest is the efficient prolonged movement that the RBC motors display in the bloodstream 
over an extended period of time with no apparent biofouling effects. The RBC membrane 
serves as an intrinsic shield to protect the magnetic nanoparticles from etching by co-
existing ions (e.g., chlorides, phosphates) in the blood, hence obviating the need for 
commonly used protective coating.36 Moreover, one of the most important factors of 
micromotors for biomedical applications is biocompatibility, or the ability of the motors to 
prevent detection and uptake by immune cells such as macrophages. Due to their inherent 
biomimetic properties, the new RBC motors are not susceptible to uptake by macrophages, 
displaying remarkable biocompatibility essential for practical biomedical uses.
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The new RBC motors were prepared using a hypotonic dilution/encapsulation method to 
load iron oxide nanoparticles (20 nm) into RBCs (Figure 1b).37 In the experiment, the RBCs 
were briefly incubated with citrate-stabilized iron-oxide nanoparticles in hypoosmotic lysing 
buffer to undergo a hypotonic hemolysis process at low temperature (4 °C). It has been 
reported that the influx of fluid creates pores with a diameter of up to 100 nm in the RBC 
membrane.38 These nanopores allow for inward diffusion of the magnetic nanoparticles 
from the surrounding medium into the cell and in parallel allow for outward diffusion of 
intracellular hemoglobin protein. The cells were held at low temperature for one hour so that 
the inner and outer particle concentrations reach equilibrium. Upon equilibrium, the solution 
reached isotonicity, when the cell membrane resealed by restoration of osmolarity. The 
temperature was then increased to 37 °C and the encapsulated magnetic nanoparticles were 
trapped inside the RBCs. Such loading protocol resulted in efficient encapsulation of 
magnetic nanoparticles into cells while minimizing damage to the cell membrane. The 
optical microscope image in Figure 1c demonstrates that the RBC motors mostly retain the 
characteristic erythrocyte shape with a diameter of 6–8 μm. The transmission electron 
microscopy (TEM) image in Figure 1d shows the magnetic nanoparticles as black spots 
within the RBC, located primarily inside the cell. During the hypotonic process, the 
nanoparticles aggregate asymmetrically within the RBCs into large magnetic particles, 39–41 
which reflects the interaction between the nanoparticles and the remaining hemoglobin 
proteins to form an agglomerate. Such asymmetric distribution of the magnetic nanoparticle 
aggregates provides a net magnetization to the cellular structure that subsequently allows 
magnetic alignment under an external magnetic field.
The RBC motors are acoustically powered and magnetically guided by an applied, external 
magnetic field. In order to prove that the RBC motors hold efficient guided motion under the 
combination of ultrasound and magnetic fields, a set of control experiments was conducted 
under different combinations of these external stimuli. Figure 2a and corresponding 
supplementary movie S1 show that the position of the RBC motor remained static in the 
absence of both ultrasound and magnetic fields. Application of a rotating magnetic field to 
the RBC motor, in the absence of ultrasound field, resulted in corresponding rotation of the 
motor, yet without its displacement (Figure 2b and Video S1), reflecting that the magnetic 
field affects only the orientation of the magnetic nanoparticles inside the RBC motor. Such 
magnetically-driven rotation was not observed for regular RBCs that do not contain internal 
magnetic nanoparticles (Figure 2c and Video S1). Application of an ultrasound field alone to 
the RBC motor led to directional motion of the motor, as displayed by the tracking line in 
Figure 2d and Video S1. It has been well documented that blood cells and microrganisms 
migrate toward pressure nodes under the ultrasound field.33 However, such responses of 
regular cells are different from the controlled propulsion of MNPs-loaded RBC motors. As 
illustrated in Figure 2e and Video S1, the simultaneous application of both the ultrasound 
and magnetic fields results in a guided motion of the RBC motor, reflecting the reversible 
alignment of the magnetization vector (discussed below). In order to confirm that this 
guided motion is selective to the RBC motors and not to other coexisting micro-objects, 
additional control experiments were performed by using regular RBCs (non-magnetic) as a 
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negative control. Figure 2f and corresponding Supplementary Video S1 illustrate that when 
both ultrasound and magnetic fields were applied to the system containing the regular and 
magnetic RBCs, only the RBC motors exhibited controlled motion (with a “Z” shape 
trajectory).
The magneto-switchable guidance of the RBC motor is demonstrated in Figure 3. 
Application of the magnetic field (while the ultrasound power is on) provides a net 
magnetization that enables magnetic alignment and reversible guidance under the acoustic 
propulsion (Figure 3a). The time-lapse image in Figure 3b and 3c illustrates such reversible, 
magneto-switchable, controlled acoustic propulsion. The on/off magnetic switching allowed 
the motion of the RBC motor to be periodically re-oriented (Figure 3b, c). Compared with 
the controlled movement of the RBC motor (Figure 3b), the natural RBC exhibited no 
significant change in direction upon turning the magnetic field on or off (Figure 3c). The 
switchable behavior of the RBC motor observed in Figure 3 demonstrates the crucial role of 
the magnetic nanoparticles in controlling the direction of the ultrasound-powered RBC 
motor. We hypothesize that the ultrasound propulsion of the RBC motor is caused by an 
asymmetric distribution of the encapsulated magnetic nanoparticles inside the RBC motor 
(that leads to asymmetric intracellular density gradient) as well as the inherent asymmetric 
geometry of the RBC. Further, the asymmetry of the magnetic particles within the RBC 
creates a net magnetization within the cell in the presence of the magnetic field. The latter 
aligns the magnetization vector to become parallel with the field, altering the direction of the 
asymmetry. The magnetic orientation of the RBC motors can thus be switched ‘On’ and 
‘Off’ by applying an external magnetic field. This data clearly indicates that encapsulating 
magnetic nanoparticles into the RBC motors, along with application of magnetic field, are 
essential for creating guided motion under the ultrasound field.
For practical biomedical applications, it is critical to test the propulsion performance of the 
RBC motor in relevant biological environments.42 As illustrated in Figure 4a and 
corresponding Video S3, the RBC motors can operate readily in diverse media ranging from 
PBS buffer solution to undiluted whole blood. The ultrasound-powered RBC motors display 
a linear movement under the magnetic alignment. The 3 second track lines of such 
movement (Figure 4a) indicate that the speed of the RBC motor decreased from 16 μm/s in 
the PBS solution to 13, 12, and 5 μm/s in the cell medium, serum, and whole blood, 
respectively, reflecting the increased environmental viscosity of these biofluids. The average 
speeds of the RBC motor in different biological media are measure and displayed in Figure 
4b. While these media affect the motor speed, the RBC motor still moves efficiently in the 
different environments, indicating the robustness of the motor for diverse biomedical 
applications.
Of particular biomedical significance is the efficient propulsion and behavior of the RBC 
motor in undiluted whole blood. Most of the previous micromotor studies in biological 
fluids were focused on serum or highly diluted blood samples. Ghosh reported recently the 
magnetically actuated movement of cytocompatible ferrite-coated helical nanohelices in 
whole blood.36 The RBC motor displayed magnetically-guided movement in undiluted 
whole blood over both short and long periods, consistent with the long life span of natural 
RBCs.43 For example, the time-lapse images in Figure 4c and corresponding Video S4 
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illustrate controlled movement of RBC motors through whole blood at 15 minute intervals 
over a 30 minute period. During this prolonged operation the motor displayed not only 
controllable movement with orthogonal turning, but also a negligible change of speed (14 
μm/s at 0 minute, 13 μm/s at 15 minute, and 14 μm/s at 30 minute). Figure 4d illustrates such 
propulsion of the RBC motor in whole blood along a predetermined Z-shaped trajectory. To 
demonstrate their resistance to biofouling, the RBC motor was incubated in undiluted whole 
blood for 24 hours followed by testing its performance. As shown in Figure 4d,e and Video 
S5, the motor exhibits a similar magnetically-guided acoustic propulsion before and after the 
incubation; the “Z” trajectory of the RBC motor and the migration of regular RBCs with a 
speed of 5 μm/s can be observed. Note that such long immersion in whole blood has a 
minimal effect upon the speed of the RBC motor (12 vs 11 μm/s, before vs after the 
incubation), reflecting the absence of protein biofouling and salt-etching effects on the 
motor behavior. Overall, the data of Figure 4 clearly indicates that RBC motor can operate 
in diverse environments, confirming the protection of the magnetic nanoparticles by the 
RBC membrane.
An important feature of the RBC motor is its anti-phagocytosis capability against 
macrophages which is crucial for evading the immune attack for prolong lifetime in the 
bloodstream. Given that the RBC motor retains intact membrane structure and antigens of 
natural RBCs including CD47 that prevents phagocytosis by macrophages through its 
interaction with inhibitory receptor SIRPα.44,45 Therefore, the RBC motor is expected to 
share the functionality of natural RBCs. To investigate the biocompatibility of the RBC 
motor, a macrophage uptake study was carried out by cultivating the J774 murine 
macrophage cells with RBC motors or unencapsulated magnetic nanoparticles for 1 hour. To 
establish samples with equal amounts of iron, the magnetic nanoparticles were obtained 
from same amount of RBC motors which are completely lysed by the addition of Triton 
X-100. The macrophages with natural RBCs were cultivated as a background control, which 
showed negligible uptake of RBCs (Figure 5a). Similar to natural RBCs, the RBC motors 
showed inhibited macrophage uptake as well (Figure 5b). In contrast, the incubation of 
macrophages with unencapsulated magnetic nanoparticles resulted in a significant number 
of dark spots in the intracellular and perinuclear regions of the cells, indicating that the 
magnetic nanoparticles were actively taken up by the cells (Figure 5c). Inductively-coupled 
plasma/mass spectrometry (ICP-MS) analysis was conducted to further quantify the iron 
uptake by the macrophage cells. As shown in Figure 5d, an uptake of 22.88 ng iron per 1000 
cells was observed from the magnetic nanoparticles, while the RBC motors had an uptake of 
2.38 ng per 1000 macrophage cells. The near 10-fold reduction in the amount of iron clearly 
demonstrates that the RBC motor can effectively inhibit the uptake by the macrophage cells. 
The inhibition is largely due to the immunosuppressive antigens of the RBC membrane 
present on the RBC motors; the encapsulation of magnetic particles exhibits a negligible 
effect on the stealthy properties of the RBC.
To test the tolerability of regular RBCs to the long period of ultrasound treatment, we next 
examined the properties of natural RBCs propelled by ultrasound at different transducer 
voltages (1–6 V) for a period of 1 hour. The images of Figure 6a,b show a 1% suspension of 
regular RBCs before and after the ultrasound treatment, respectively. The geometry of RBCs 
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exhibited negligible change after the treatment, indicating that the ultrasound field did not 
cause adverse effect on the RBCs. Moreover, the absorption spectrum of regular RBCs, over 
the 300–800 nm wavelength range, showed no detectable change at various ultrasound 
powers (Figure 6c). The ultrasound-treated regular RBCs were next subject to hemolytic 
lysis to quantify the remaining hemoglobin within these cells by measuring the hemoglobin 
absorbance at 540 nm. We found that all hemoglobin was retained inside the cells after the 
ultrasound treatment, corresponding to near 100% hemolysis after the hemolytic treatment 
(Figure 6d). Such negligible change in the degree of hemolysis further confirms the stability 
of regular RBCs under the ultrasound field.
CONCLUSIONS
We reported an RBC-derived approach for developing a new generation of cell-based 
micromotor that is powered by ultrasound and activated by a magnetic field. The RBC 
motor was fabricated by loading magnetic nanoparticles into natural RBCs. Switchable 
guided propulsion of RBC motors can be achieved by using a combination of the ultrasound 
and magnetic fields. The RBC motors can perform controlled propulsion in undiluted whole 
blood over extended periods with no apparent biofouling. The inhibited macrophage uptake 
confirms the biocompatibility of the RBC motors. The ability to load natural RBCs with a 
variety of functional components,46 together with the efficient propulsion in a broad 
spectrum of biological fluids, holds great promise for developing multifunctional cell-based 
micromotors for a variety of in vitro and in vivo biomedical applications, and for bridging 
the gap between synthetic motors and the biological world.
EXPERIMENTAL SECTION
Synthesis of Citrate-Stabilized Magnetic Nanoparticles
Citrate-stabilized Fe3O4 nanoparticles were synthesized using the previously reported 
protocol.47 Briefly, a mixture of 0.43 g of FeCl2 and 0.70 g of FeCl3 was mixed in 40 mL of 
water, which was degassed with nitrogen before mixing under the protection of nitrogen. 
Subsequently, 2 mL of NH4OH were added to the mixture solution under vigorous stirring 
and heated at 80 °C for additional 30 minutes. The supernatant was discarded while the 
nanoparticles were obtained in the reaction flask using a magnet, and then fresh degassed 
water was added. Citric acid solution (2 mL, 0.5 g/mL) was added, and the reaction mixture 
was maintained at 95 °C for 90 minutes. The reaction mixture was allowed to cool to room 
temperature under nitrogen. The nanoparticle suspension was washed three times with 
deionized water and then collected for the subsequent use.
Encapsulation of Magnetic Particles in RBCs
Fresh RBCs were collected from six-week-old male ICR mice and anti-coagulated with 
ethylenediamine tetraacetate. The cells were rinsed three times with PBS (300 mOsm, pH 
8). For encapsulating magnetic nanoparticles into the RBCs, 300 μL suspension of RBC and 
300 μL suspension of citrate-stabilized iron-oxide nanoparticles were mixed, which led to a 
hypotonic condition (final osmotic pressure in RBC suspension, 100–160 mOsm). The 
RBCs were incubated under stirring at 4 °C for 1 h. The loaded RBCs were washed three 
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times with PBS (300 mOsm, pH = 8) at room temperature to remove the free hemoglobin 
and excess Fe3O4 nanoparticles. The resulting RBCs were resealed by incubation in 100 mL 
PBS at 37 °C for 1h.
Ultrasound Equipment
The ultrasound experiments were carried out in a cell, as was reported previously.48,49 The 
cell was made in a covered glass slide (75 x 25 x 1 mm). A piezoelectric transducer (PZT), 
consisting of a 0.5 mm thick ring with a 10 mm outside diameter and 5 mm inner diameter 
was attached to the bottom center of the glass slide to create the ultrasonic field. The 
continuous ultrasound sine wave was applied through the PZT, via an Agilent 15MHz 
arbitrary waveform generator, which was connected to a power amplifier. The continuous 
sine waveform had a frequency of 2.93 MHz and a voltage amplitude varied between 0 and 
10.0 V, as needed for controlling the intensity of the ultrasonic wave. The electric signal was 
monitored using a 20 MHz Tektronix 434 storage oscilloscope.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Red blood cells (RBC) motors. (a) Schematic illustration of magnetically-guided, 
ultrasound-propelled RBC micromotors in whole blood. (b) The preparation of the RBC 
motors: magnetic nanoparticles are loaded into regular RBCs by using a hypotonic dilution 
encapsulation method. (c) Optical and (d) transmission electron microscopy images of the 
RBC motors.
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The propulsion performance of RBC motors. The RBC motor, suspended in PBS solution, 
was subjected to various external stimulus conditions, including (a) without any stimulus; 
(b) under magnetic field alone; (c) under magnetic field in the presence of regular (non-
magnetic) RBCs; (d) under ultrasound field alone; (e) under both magnetic and ultrasound 
fields; and (f) under both magnetic and ultrasound fields in the presence of regular RBCs 
(non-magnetic). Scale bars, 20 μm. Corresponding videos are provided in the supplementary 
information (Video S1).
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Magneto-switchable guidance of ultrasound-powered RBC motor. (a) Schematic illustration 
showing the projected motion trajectory of the RBC motor under ultrasound field with On-
Off switchable magnetic field. (b) Actual time-lapse image, from corresponding Video S2, 
illustrating the movement of the RBC motor under ultrasound field upon turning the 
magnetic field On and Off; (c) as in (b) but in the presence of a regular natural RBC as a 
control. Scale bars, 20 μm.
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Movement of RBC motors in various media. (a) Images illustrating the propulsion of the 
RBC motor in PBS, cell culture, serum, and whole blood, taken from corresponding Video 
S3. (b) The quantitative velocity of the RBC motor in different media at ultrasound voltage 
of 3 V and a frequency of 2.93 MHz. (c) Swimming behavior of the RBC motor in undiluted 
whole blood over 30 minutes, taken from corresponding Video S4. Scale bars, 10 μm. (d, e) 
Images showing the propulsion of the RBC motor in whole blood before (d) and after (e) a 
24 hour incubation in the whole blood, respectively. Scale bars, 10 μm.
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A macrophage uptake study to illustrate the biocompatibility of RBC motors. (a–c) Bright 
field microscopic images of J774 murine macrophage cells incubated for 30 minutes, with 
regular RBCs, RBC motors, and iron-oxide nanoparticles (Fe3O4 NPs, with equal amounts 
of iron to that of the RBC motors), respectively. (d) Quantitative analysis of macrophage 
uptake of RBC motors and iron oxide NPs determined by ICP-MS measurements.
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Tolerability of regular RBCs under ultrasound operations. (a and b) Optical images of 
regular RBCs before and after the ultrasonic treatment, respectively. Scale bars, 2 μm. (c) 
Absorption spectra of regular RBCs under ultrasound field with an applied frequency of 
2.93 MHz and at different transducer voltages (0–6 V). (d) The relative hemolysis of regular 
RBCs under various ultrasound transducer voltages.
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